Thumbnail Image
Publication

Revert the SIRT: normalizing SIRT1 activity in myelodysplastic stem cells.

Simeoni, Fabrizio
; 
Somervaille, Tim C P
Citations
Altmetric:
Abstract
Myelodysplastic syndromes are hematologic malignancies with few treatment options and a propensity to transform to acute myeloid leukemia. In this issue of Cell Stem Cell, Sun et al. (2018) report that low SIRT1 levels in myelodysplastic stem cells contribute to aberrant self-renewal through enabling hyperacetylation and reduced activity of TET2.
Authors
Simeoni, Fabrizio
Somervaille, Tim C P
Affiliation
Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4JG, UK
Description
Date
2018-09-06
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Type
Article
Citation
Revert the SIRT: normalizing SIRT1 activity in myelodysplastic stem cells. 2018, 23(3): 315-317 Cell Stem Cell
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/621294
Embedded videos